Lemaitre Vascular (LMAT) EBITDA Margin (2010 - 2026)
Lemaitre Vascular (LMAT) posted quarterly EBITDA Margin of 26.71% for Q1 2026, up 562.0% year-over-year from 4.03% in Q1 2025, and down 8.59% quarter-over-quarter from 29.22% in Q4 2025.
Lemaitre Vascular (LMAT) EBITDA Margin (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has reported EBITDA Margin for 17 consecutive years, with 26.71% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 562.0% year-over-year to 26.71%; the TTM figure through Mar 2026 stood at 28.51% (up 508.0% YoY), while the FY2025 annual figure was 27.21%, up 344.0% from the prior year.
- EBITDA Margin retreated to 26.71% in Q1 2026 per LMAT's latest filing, from 29.22% in the prior quarter.
- Across five years, EBITDA Margin topped out at 33.27% in Q3 2025 and bottomed at 13.74% in Q2 2022.
- Historically, EBITDA Margin has averaged 21.93% across 5 years, with a median of 21.09% in 2025.
- Annual changes were most pronounced in 2022 — EBITDA Margin tumbled 1357 bps — and 2025, when it surged 929 bps.
- Lemaitre Vascular's EBITDA Margin stood at 17.01% in 2022, then gained by 23 bps to 20.88% in 2023, then rose by 10 bps to 23.07% in 2024, then advanced by 27 bps to 29.22% in 2025, then retreated by 9 bps to 26.71% in 2026.
- Business Quant data shows LMAT's EBITDA Margin at 26.71% in Q1 2026, 29.22% in Q4 2025, and 33.27% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 33.60% |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 13.31% |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 0.39% |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 30.66% |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 5.14% |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 20.53% |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 8.19% |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | -2.87% |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 7.33% |
| 10 | Lemaitre Vascular | 1.88 Bn | 1.50 Bn | 50.76 Mn | 28.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.98% |
| Mar 31, 2026 | 26.71% |
| Dec 31, 2025 | 29.22% |
| Sep 30, 2025 | 33.27% |
| Jun 30, 2025 | 25.13% |
| Mar 31, 2025 | 21.09% |
| Dec 31, 2024 | 23.07% |
| Sep 30, 2024 | 23.98% |
| Jun 30, 2024 | 25.75% |
| Mar 31, 2024 | 22.20% |
| Dec 31, 2023 | 20.88% |
| Sep 30, 2023 | 19.36% |
| Jun 30, 2023 | 18.86% |
| Mar 31, 2023 | 16.73% |
| Dec 31, 2022 | 17.01% |
| Sep 30, 2022 | 15.76% |
| Jun 30, 2022 | 13.74% |
| Mar 31, 2022 | 20.04% |
| Dec 31, 2021 | 21.01% |
| Sep 30, 2021 | 23.65% |